Hallett David 4

4 · RECURSION PHARMACEUTICALS, INC. · Filed Feb 10, 2026

AI-generated summary of this filing

Updated Feb 10, 2026

Recursion (RXRX) CSO David Hallett Receives RSU Award; 11,400 Shares Withheld

What Happened

David Hallett, Chief Scientific Officer of Recursion Pharmaceuticals (RXRX), was granted a total of 526,318 restricted stock units (RSUs) on Feb 6, 2026 (502,064 + 24,254 units). Concurrently, 11,400 shares were withheld to satisfy tax withholding obligations at $3.98 per share (total withheld value $45,372). The awards are grants (not purchases or open-market sales).

Key Details

Transaction date: 2026-02-06; Form filed: 2026-02-10 (filed within the typical 2-business-day window).
Grant prices reported as $0.00 (standard for RSU awards); withholding executed at $3.98/share (11,400 shares; $45,372).
Total RSUs granted: 526,318 (502,064 + 24,254).
Shares owned after the transaction: not specified in the provided filing data.
Footnotes:
- F1: One RSU award vests 1/16 on May 15, 2026 and then quarterly thereafter.
- F2: The smaller RSU award vested immediately on the grant date.
- F3: The 11,400 shares were withheld by the issuer to satisfy tax withholding in connection with net settlement of RSUs (routine tax withholding).

Context

These transactions are equity awards (RSUs). The withholding of shares to cover taxes is a common, administrative action (not an open-market sale by the insider).
No indication in the filing of option exercises, open-market purchases, gifts, or a 10b5-1 plan. The grant that vests over time suggests future vesting-based retention rather than an immediate liquidity event.

Form 4

Period: 2026-02-06

Chief Scientific Officer

Transactions

Award
Class A Common Stock
[F1]
2026-02-06+502,064→ 1,096,205 total
Award
Class A Common Stock
[F2]
2026-02-06+24,254→ 1,120,459 total
Tax Payment
Class A Common Stock
[F3]
2026-02-06$3.98/sh−11,400$45,372→ 1,109,059 total

Footnotes (3)

[F1]This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter.
[F2]This RSU vested immediately upon the grant date.
[F3]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.

Signature

/s/ Kyle Nelson, attorney-in-fact|2026-02-10

1 file